MediSieve is a medical device therapeutics company developing “magnetic blood filtration”, a revolutionary method of treating blood-borne diseases by removing pathogens directly from a patient’s bloodstream. Practically any component can be specifically targeted and removed, providing a platform technology that could treat a huge range of conditions, accessing several billion-dollar markets. The first applications are in sepsis, leukaemia and malaria. MediSieve products include magnetic particles, which bind specific targets in blood, and a magnetic filter which captures and removes the particles and targets. The filter will undergo clinical trials in Q2 2019. The particles are currently being validated in vitro.,MediSieve is a medical device therapeutics company developing “magnetic blood filtration”, a revolutionary method of treating blood-borne diseases by removing pathogens directly from a patient’s bloodstream. Practically any component can be specifically targeted and removed, providing a platform technology that could treat a huge range of conditions, accessing several billion-dollar markets. The first applications are in sepsis, leukaemia and malaria. MediSieve products include magnetic particles, which bind specific targets in blood, and a magnetic filter which captures and removes the particles and targets. The filter will undergo clinical trials in Q2 2019. The particles are currently being validated in vitro.